Reading the graph
Windrose Health Investors, LLC · organization
observed in a filing or announcement; the statement is the source's
WindRose Health Investors Announces Recapitalization of Verified Clinical Trials
Why now: Dated 2026-08-06 (document); first seen by DFX 2026-09-15.
Buyer classes for this family: Private credit lenders, Investment bankers, PE sponsors, Independent sponsors.
a dated platform deal names sponsor and company; lenders, bankers and add-on sellers act on it. Evidence class: fact; source Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS).
DFX product: PE Acquisition Intelligence
the announcement is a minority or growth stake
Dated 2026-09-18 (document); first seen by DFX 2026-09-18.
Rank 45.0: consequence 4, commercial 4, timeliness 4, novelty 5, confidence 3, magnitude 0, affected 2, actionability 3
Family pc.platform_acquisition · public · computed today
Dated 2026-09-18 (document); first seen by DFX 2026-09-19.
Dated 2026-09-18 (document); first seen by DFX 2026-09-18.
Dated 2026-09-17 (document); first seen by DFX 2026-09-18.
Dated 2026-09-17 (document); first seen by DFX 2026-09-17.
Dated 2026-09-17 (document); first seen by DFX 2026-09-17.